Evaluation of therapeutic modalities in patients with life threatening arrhythmias.
Teo
K K
KK
Division of Cardiology, University of Alberta, Edmonton.
D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D001281:Atrial Fibrillation / Q000628:therapy; D002170:Canada; D003645:Death, Sudden; D017147:Defibrillators, Implantable; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications / Q000628:therapy; D010919:Placebos; D014693:Ventricular Fibrillation / Q000628:therapy
D000889:Anti-Arrhythmia Agents; D010919:Placebos